Boothbay Fund Management, LLC Aptevo Therapeutics Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.48 - $17.49 $99,468 - $268,471
-15,350 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$21.85 - $30.0 $15,732 - $21,600
720 Added 4.92%
15,350 $344,000
Q1 2021

May 17, 2021
BUY
$27.86 - $40.59 $87,396 - $127,330
3,137 Added 27.29%
14,630 $447,000
Q4 2020

Feb 12, 2021
BUY
$6.21 - $48.36 $71,371 - $555,801
11,493 New
11,493 $421,000

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $24.5M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email